UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The MET receptor tyrosine kinase in invasion and metastasis

Journal of cellular physiology, 2007-11, Vol.213 (2), p.316-325

2007

Volltextzugriff (PDF)

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (6), p.2643-2648

2007

Volltextzugriff (PDF)

Lung-Seeking Metastases

Cancers, 2019-07, Vol.11 (7), p.1010

2019

Volltextzugriff (PDF)

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

The lancet oncology, 2005-05, Vol.6 (5), p.279-286

2005

Volltextzugriff (PDF)

The ROR1 pseudokinase diversifies signaling outputs in MET‐addicted cancer cells

International journal of cancer, 2014-11, Vol.135 (10), p.2305-2316

2014

Volltextzugriff (PDF)

Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition

Nature communications, 2021-05, Vol.12 (1), p.2498-2498, Article 2498

2021

Volltextzugriff (PDF)

Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge

Cancers, 2020-05, Vol.12 (5), p.1186

2020

Volltextzugriff (PDF)

MET Exon 14 Skipping: A Case Study for the Detection of Genetic Variants in Cancer Driver Genes by Deep Learning

International journal of molecular sciences, 2021-04, Vol.22 (8), p.4217

2021

Volltextzugriff (PDF)

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

EMBO molecular medicine, 2020-07, Vol.12 (7), p.e11756-n/a

2020

Volltextzugriff (PDF)

Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

Journal of translational medicine, 2016-09, Vol.14 (1), p.256-256, Article 256

2016

Volltextzugriff (PDF)

Brain Metastases from Lung Cancer: Is MET an Actionable Target?

Cancers, 2019-02, Vol.11 (3), p.271

2019

Volltextzugriff (PDF)

From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary Perspective

Cancers, 2020-08, Vol.12 (8), p.2105

2020

Volltextzugriff (PDF)

Erratum to: Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

Journal of translational medicine, 2017-09, Vol.15 (1), p.194-194, Article 194

2017

Volltextzugriff (PDF)

Erratum: Stella, G.M. et al. Brain Metastases from Lung Cancer: Is MET an Actionable Target? Cancers 2019, 11 , 271

Cancers, 2019-05, Vol.11 (5), p.644

2019

Volltextzugriff (PDF)

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin

EBioMedicine, 2017-10, Vol.24 (C), p.34-42

2017

Volltextzugriff (PDF)

Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation

Advanced pharmaceutical bulletin, 2017-04, Vol.7 (1), p.141-150

2017

Volltextzugriff (PDF)

RON tyrosine kinase mutations in brain metastases from lung cancer

ERJ open research, 2018-01, Vol.4 (1), p.83

2018

Volltextzugriff (PDF)

Comunicare la matematica: un paradigma necessario, che fatica a essere accolto

Quaderni di Comunicazione Scientifica, 2021, Vol.1 (1), p.33

2021

Volltextzugriff (PDF)

Phosphatase protein homologue to tensin expression and phosphatidylinositol-3 phosphate kinase mutations in colorectal cancer

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (23), p.11227-11227

2005

Volltextzugriff (PDF)

Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8), p.3132-3141

2011

Volltextzugriff (PDF)

Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation

Proceedings of the National Academy of Sciences - PNAS, 2018-10, Vol.115 (40), p.10058-10063

2018

Volltextzugriff (PDF)

PRL-3: A phosphatase for metastasis?

Cancer biology & therapy, 2004-10, Vol.3 (10), p.952-953

2004

Volltextzugriff (PDF)

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

Virchows Archiv : an international journal of pathology, 2023-03, Vol.482 (3), p.463-475

2023

Volltextzugriff (PDF)

A Peptide Representing the Carboxyl-terminal Tail of the Met Receptor Inhibits Kinase Activity and Invasive Growth

The Journal of biological chemistry, 1999-10, Vol.274 (41), p.29274-29281

1999

Volltextzugriff (PDF)

Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery

Journal of Cancer Research & Clinical Oncology, 2016-12, Vol.142 (12), p.2429-2446

2016

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(141)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Arquivos Brasileiros De Cardiologia
(11)
Cancer Research
(6)
Cancers
(6)
Blood
(4)
Gastroenterology
(4)
Advanced Pharmaceutical Bulletin
(3)
Cardiovascular Pathology
(3)
Human Mutation
(3)
Oncogene
(3)
Plos One
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The MET receptor tyrosine kinase in invasion and metastasis

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies

Lung-Seeking Metastases

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

The ROR1 pseudokinase diversifies signaling outputs in MET‐addicted cancer cells

Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition

Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge

MET Exon 14 Skipping: A Case Study for the Detection of Genetic Variants in Cancer Driver Genes by Deep Learning

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

Brain Metastases from Lung Cancer: Is MET an Actionable Target?

From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers—A Multidisciplinary Perspective

Erratum to: Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer

Erratum: Stella, G.M. et al. Brain Metastases from Lung Cancer: Is MET an Actionable Target? Cancers 2019, 11 , 271

MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin

Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using In Silico Alanine Scanning Mutagenesis and Molecular Dynamics Simulation

RON tyrosine kinase mutations in brain metastases from lung cancer

Comunicare la matematica: un paradigma necessario, che fatica a essere accolto

Phosphatase protein homologue to tensin expression and phosphatidylinositol-3 phosphate kinase mutations in colorectal cancer

Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis

Reviving oncogenic addiction to MET bypassed by BRAF (G469A) mutation

PRL-3: A phosphatase for metastasis?

Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs)

A Peptide Representing the Carboxyl-terminal Tail of the Met Receptor Inhibits Kinase Activity and Invasive Growth

Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery

Suchergebnisse filtern